Clinical and translational advances in glioma immunotherapy: review
Gliomas are highly treatment refractory against immune checkpoint blockade, an immunotherapeutic modality that revolutionized therapy for many tumors. At the same time, technological innovation has dramatically accelerated the development of immunotherapeutic approaches such as personalized tumor-sp...
Gespeichert in:
| Hauptverfasser: | , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
October 2022
|
| In: |
Neurotherapeutics
Year: 2022, Jahrgang: 19, Heft: 6, Pages: 1799-1817 |
| ISSN: | 1878-7479 |
| DOI: | 10.1007/s13311-022-01313-9 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1007/s13311-022-01313-9 Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S1878747923001344 
|
| Verfasserangaben: | Lukas Bunse, Theresa Bunse, Christopher Krämer, Yu-Chan Chih, Michael Platten |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 187939281X | ||
| 003 | DE-627 | ||
| 005 | 20240307080209.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240129s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s13311-022-01313-9 |2 doi | |
| 035 | |a (DE-627)187939281X | ||
| 035 | |a (DE-599)KXP187939281X | ||
| 035 | |a (OCoLC)1425215401 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Bunse, Lukas |d 1988- |e VerfasserIn |0 (DE-588)1051941229 |0 (DE-627)787187399 |0 (DE-576)407600426 |4 aut | |
| 245 | 1 | 0 | |a Clinical and translational advances in glioma immunotherapy |b review |c Lukas Bunse, Theresa Bunse, Christopher Krämer, Yu-Chan Chih, Michael Platten |
| 264 | 1 | |c October 2022 | |
| 300 | |b Illustrationen | ||
| 300 | |a 19 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Online verfügbar: 27. Oktober 2022, Artikelversion: 1. Januar 2024 | ||
| 500 | |a Gesehen am 29.01.2024 | ||
| 520 | |a Gliomas are highly treatment refractory against immune checkpoint blockade, an immunotherapeutic modality that revolutionized therapy for many tumors. At the same time, technological innovation has dramatically accelerated the development of immunotherapeutic approaches such as personalized tumor-specific vaccine production, dendritic cell vaccine manufacture, patient-individual target selection and chimeric antigen receptor, and T cell receptor T cell manufacture. Here we review recent clinical and translational advances in glioma immunotherapy with a focus on targets and their cognate immune receptor derivates as well as concepts to improve intratumoral T cell effector functions. | ||
| 650 | 4 | |a Combinatorial immunotherapy | |
| 650 | 4 | |a Glioma antigens | |
| 650 | 4 | |a Glioma immunotherapy | |
| 650 | 4 | |a Neoepitopes | |
| 650 | 4 | |a Peptide vaccines | |
| 650 | 4 | |a Personalized immunotherapy | |
| 650 | 4 | |a T cell therapy | |
| 700 | 1 | |a Bunse, Theresa |d 1985- |e VerfasserIn |0 (DE-588)105282112X |0 (DE-627)789079070 |0 (DE-576)408553731 |4 aut | |
| 700 | 1 | |a Krämer, Christopher |d 1997- |e VerfasserIn |0 (DE-588)1279191635 |0 (DE-627)1832479978 |4 aut | |
| 700 | 1 | |a Chih, Yu-Chan |d 1997- |e VerfasserIn |0 (DE-588)1317602609 |0 (DE-627)1879494531 |4 aut | |
| 700 | 1 | |a Platten, Michael |d 1971- |e VerfasserIn |0 (DE-588)121627780 |0 (DE-627)081431848 |0 (DE-576)261969811 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Neurotherapeutics |d [Amsterdam] : Elsevier B.V., 2007 |g 19(2022), 6 vom: Okt., Seite 1799-1817 |h Online-Ressource |w (DE-627)527833967 |w (DE-600)2279496-7 |w (DE-576)272351261 |x 1878-7479 |7 nnas |a Clinical and translational advances in glioma immunotherapy review |
| 773 | 1 | 8 | |g volume:19 |g year:2022 |g number:6 |g month:10 |g pages:1799-1817 |g extent:19 |a Clinical and translational advances in glioma immunotherapy review |
| 856 | 4 | 0 | |u https://doi.org/10.1007/s13311-022-01313-9 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://www.sciencedirect.com/science/article/pii/S1878747923001344 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20240129 | ||
| 993 | |a Article | ||
| 994 | |a 2022 | ||
| 998 | |g 121627780 |a Platten, Michael |m 121627780:Platten, Michael |d 60000 |d 62700 |d 60000 |d 65100 |e 60000PP121627780 |e 62700PP121627780 |e 60000PP121627780 |e 65100PP121627780 |k 0/60000/ |k 1/60000/62700/ |k 0/60000/ |k 1/60000/65100/ |p 5 |y j | ||
| 998 | |g 1317602609 |a Chih, Yu-Chan |m 1317602609:Chih, Yu-Chan |d 140000 |e 140000PC1317602609 |k 0/140000/ |p 4 | ||
| 998 | |g 1279191635 |a Krämer, Christopher |m 1279191635:Krämer, Christopher |d 50000 |d 53100 |e 50000PK1279191635 |e 53100PK1279191635 |k 0/50000/ |k 1/50000/53100/ |p 3 | ||
| 998 | |g 105282112X |a Bunse, Theresa |m 105282112X:Bunse, Theresa |d 60000 |d 62700 |e 60000PB105282112X |e 62700PB105282112X |k 0/60000/ |k 1/60000/62700/ |p 2 | ||
| 998 | |g 1051941229 |a Bunse, Lukas |m 1051941229:Bunse, Lukas |d 60000 |d 62700 |e 60000PB1051941229 |e 62700PB1051941229 |k 0/60000/ |k 1/60000/62700/ |p 1 |x j | ||
| 999 | |a KXP-PPN187939281X |e 4471836315 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"relHost":[{"disp":"Clinical and translational advances in glioma immunotherapy reviewNeurotherapeutics","origin":[{"dateIssuedDisp":"2007-","publisherPlace":"[Amsterdam] ; New York, NY [u.a.] ; New York, NY","dateIssuedKey":"2007","publisher":"Elsevier B.V. ; Elsevier ; Springer"}],"corporate":[{"role":"isb","display":"American Society for Experimental Neurotherapeutics"}],"id":{"zdb":["2279496-7"],"eki":["527833967"],"issn":["1878-7479"]},"recId":"527833967","type":{"media":"Online-Ressource","bibl":"periodical"},"pubHistory":["4.2007 -"],"note":["Fortsetzung der Druck-Ausgabe","Gesehen am 16.05.2024"],"language":["eng"],"part":{"volume":"19","text":"19(2022), 6 vom: Okt., Seite 1799-1817","issue":"6","year":"2022","pages":"1799-1817","extent":"19"},"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title":"Neurotherapeutics","subtitle":"official journal of the American Society for Experimental NeuroTherapeutics (ASENT)","title_sort":"Neurotherapeutics"}]}],"physDesc":[{"extent":"19 S.","noteIll":"Illustrationen"}],"title":[{"title_sort":"Clinical and translational advances in glioma immunotherapy","subtitle":"review","title":"Clinical and translational advances in glioma immunotherapy"}],"recId":"187939281X","id":{"doi":["10.1007/s13311-022-01313-9"],"eki":["187939281X"]},"type":{"bibl":"article-journal","media":"Online-Ressource"},"origin":[{"dateIssuedDisp":"October 2022","dateIssuedKey":"2022"}],"name":{"displayForm":["Lukas Bunse, Theresa Bunse, Christopher Krämer, Yu-Chan Chih, Michael Platten"]},"note":["Online verfügbar: 27. Oktober 2022, Artikelversion: 1. Januar 2024","Gesehen am 29.01.2024"],"language":["eng"],"person":[{"display":"Bunse, Lukas","role":"aut","family":"Bunse","given":"Lukas"},{"given":"Theresa","family":"Bunse","role":"aut","display":"Bunse, Theresa"},{"given":"Christopher","family":"Krämer","role":"aut","display":"Krämer, Christopher"},{"given":"Yu-Chan","role":"aut","family":"Chih","display":"Chih, Yu-Chan"},{"given":"Michael","display":"Platten, Michael","family":"Platten","role":"aut"}]} | ||
| SRT | |a BUNSELUKASCLINICALAN2022 | ||